Fred Ma
CIK 1689295 · View on SEC EDGAR ↗
First SEC filing: May 5, 2017 · Latest: May 5, 2017
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 28, 2018 | KRMD | A | 9,091 | $1.65 | $15,000 | 160,518 Direct | +6.00% | Acquired | 101.5% (price as of 2026-08-19) |
| March 29, 2018 | KRMD | A | 11,538 | $1.30 | $14,999 | 140,557 Direct | +8.94% | Acquired | 155.8% (price as of 2026-08-19) |
| Dec. 29, 2017 | KRMD | A | 12,000 | $1.25 | $15,000 | 129,019 Direct | +10.25% | Acquired | 166.0% (price as of 2026-08-19) |
| Sept. 29, 2017 | KRMD | A | 28,302 | $0.53 | $15,000 | 117,019 Direct | +31.90% | Acquired | 527.4% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 5, 2017 | KRMD | Common Stock | 46,164 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
KRMD
Former Chief Medical Officer ( 5)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $303,800 | — | $45,000 | — | — | — | $225,000 | $573,800 |
| 2017 | $250,000 | — | $65,000 | — | $60,000 | — | — | $375,000 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.